Gapping up
In reaction to strong earnings/guidance: MODN +21.3%, QIWI +13.6%, LLNW +12%, ATW +8.8%, TC +7.1%, ICUI +6.7%, VOD +6%, RAX +5%, (authorizes $500 mln share repurchase), OMEX +4.8%, PTLA +2.4%, INSY +2.2%, ESPR +2.1%, PDLI +2%, DTSI +1.3%
M&A news: PT +7.3% (cont momentum higher on M&A spec)
Other news: LITB +13.1% (following singles day in China), ANIK +5.7% ( announced that the Center for Medicare & Medicaid Services has assigned a unique Healthcare Common Procedure Coding System code, or J-Code, to its product MONOVISC), JRJC +5.3% (announces new partnership with Great Wall Securities to open online accounts and to trade real-time), PBF +5% (Baupost Group disclosed 10.37% passive stake in 13G filing), ACHN +4.3% (cont momentum higher pre-mkt after yday's 27% move), MDR +3.5% (announced that it has been awarded a three-year shallow water pipeline contract by Brunei Shell Petroleum ), JD +1.3% (following singles day in China), SAN +1.2% (still checking), SNY +1.2% (Regeneron and Sanofi announce positive results from Phase 2b study of Dupilumab ), PLUG +0.9% (names Paul Middleton as new CFO), ESLT +0.8% (awarded ~$29 mln contract to provide logistics support to the United States Air Force's F-16 head-up displays ), STNG +0.8% (declared a quarterly dividend of $0.12 per share, reflecting an increase of 20%)
Analyst comments: TRMR +6.6% (upgraded to Buy from Hold at Jefferies), ZNGA +6.5% (upgraded to Buy from Hold at Jefferies), ORBC +3% (upgraded to Overweight from Equal Weight at First Analysis Sec), IMAX +2.8% (upgraded to Buy from Neutral at Goldman), TWX +2% (upgraded to Buy from Neutral at Goldman; added to Conviction Buy list), AUY +1.6% (upgraded to Overweight from Neutral at HSBC Securities), IMPV +1.6% (initiated with a Outperform at Macquarie), CERS +1% (initiated with a Buy at Cantor Fitzgerald), BBVA +0.9% (upgraded to Buy from Reduce at Nomura )